Interactions between the body's immune system and bacteria that live in the gut become disrupted in multiple sclerosis (MS), ...

Findings from the implanted scaffold led researchers to block specific inflammatory molecules, easing disease severity in a ...

Ocrevus as a first-line treatment for early relapsing MS is better at delaying disease progression than starting with a less ...

Columnist Desiree Lama describes her journey with MS-related bladder problems that were brought under control but are now ...

An all-new, physician-led multiple sclerosis (MS) show designed to encourage and inspire you through expert insights, tips on ...

Four new SPMS patients not eligible for a Tiziana Life Sciences trial were dosed with foralumab nasal spray in an expanded access program.

Columnist Ben Hofmeister explains how songs such as "No One Is to Blame" have become part of the soundtrack of his life with MS.

Switching from CD20 inhibitors to fumarate therapies reduces healthcare visits and infection-related costs, while controlling ...

A low educational status was associated with longer delays before initiating treatment among relapsing-remitting MS patients ...

The study estimated annual mortality rates for 5,797 individuals with MS compared with 28,807 controls with a similar age, ...

TG Therapeutics will use MaxCyte’s technology to advance toward a clinical trial its azer-cel CAR T-cell therapy for ...

Stress management strategies such as mindfulness and exercise can help you manage your multiple sclerosis (MS) diagnosis.